-
Product Insights
Likelihood of Approval Analysis for Lipid Storage Disorders (Lipidoses)
Overview How likely is it that the drugs in Lipid Storage Disorders (Lipidoses) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Storage Disorders (Lipidoses) Overview Lipid storage disorders, or lipidoses,...
-
Product Insights
Likelihood of Approval Analysis for Mucopolysaccharidosis
Overview How likely is it that the drugs in Mucopolysaccharidosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mucopolysaccharidosis Overview Mucopolysaccharidosis (MPS) refers to a group of inherited metabolic disorders causing...
-
Company Insights
NewiDEAL – Competitor Profile
iDEAL - a market leader in Dutch third-party payment services—was established by payment systems provider Currence in 2005. iDEAL offers online payments for Dutch domestic and international shoppers, enabling them to pay for online purchases directly from their bank accounts. iDEAL also enables consumers to carry out other transactions such as utility bill payments, mobile top-ups, and donations. It generates business by offering five types of transactions: domestic ecommerce payments, cross-border ecommerce payments, payments between consumers, non-ecommerce payments, and buy...
-
Sector Analysis
NewReconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Reconstruction Meshes Market Report Overview The Reconstruction Meshes market size was $2.38 billion in 2023. Factors such as the rising number of breast reconstruction procedures and the growing prevalence of Pelvic Organ Prolapse (POP) will drive the market growth at a CAGR of more than 1% from 2023 to 2033. Reconstruction Meshes Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights on the Reconstruction Meshes Market Forecast, Download a Free Sample Report The Reconstruction Meshes market research...
-
Government & Regulation
NewAustralia Mining Fiscal Landscape – Regulations Governance and Sustainability
Australia Mining Fiscal Landscape Report Overview Australia has abundant and diverse natural resources, including iron ore, coal, copper, and bauxite. Therefore, mining impacts the country’s national income, investments, jobs, exports, and government revenues significantly. Australia is the largest iron ore producer globally. The country’s federal and state governments have separate roles and responsibilities pertaining to resource exploration and development. Mineral resources are owned by the Australian government, or state or territory governments, rather than private individuals. The ‘Australia Mining Fiscal...
-
Product Insights
Likelihood of Approval Analysis for Systemic Candidiasis
Overview How likely is it that the drugs in Systemic Candidiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Candidiasis Overview Systemic candidiasis encompasses a range of yeast infections resulting...
-
Product Insights
Likelihood of Approval Analysis for Complicated Intra-Abdominal Infections
Overview How likely is it that the drugs in Complicated Intra-Abdominal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Complicated Intra-Abdominal Infections Overview Complicated intra-abdominal infections (cIAIs) are infections that...
-
Product Insights
Likelihood of Approval Analysis for Fungal Infections
Overview How likely is it that the drugs in Fungal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fungal Infections Overview Fungal infections are diseases caused by different types of...
-
Product Insights
Likelihood of Approval Analysis for Lupus Nephritis
Overview How likely is it that the drugs in Lupus Nephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lupus Nephritis Overview Lupus nephritis is a severe complication of systemic lupus...
-
Product Insights
Likelihood of Approval Analysis for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Overview How likely is it that the drugs in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Overview Systemic-onset...